KO vs SBUX: Which Is the Better Buy?

Side-by-side comparison of The Coca-Cola Company and Starbucks Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-17.
The Coca-Cola Company Β· Consumer Defensive
$84.92
-10.2% upside to fair value
Grade C High Quality
VS
Starbucks Corporation Β· Consumer Cyclical
$100.65
-6.1% upside to fair value
Grade D
QuantHub Verdict
SBUX has more upside to fair value (-6.1%). KO trades at a lower forward P/E (26.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric KO SBUX
Current Price $84.92 $100.65
Fair Value Estimate $76.30 $94.50
Upside to Fair Value -10.2% -6.1%
Market Cap $365.4B $114.7B
Forward P/E 26.6x 76.7x
EV / EBITDA 20.7x 25.6x
Price / Sales 7.4x 3.0x
Price / FCF 29.1x 42.1x
Revenue Growth YoY +12.1% +8.8%
Gross Margin 61.7% 20.4%
Operating Margin 29.3% 9.3%
Return on Equity 43.6% -18.3%
Dividend Yield 0% 0%
FCF Yield 3.44% 2.38%
Analyst Consensus Strong Buy Hold
Investment Thesis
KO β€” The Coca-Cola Company
The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a durable competitive moat driven by its strong brand and extensive distribution network. The business quality is high, evidenced by a 43.6% return on equity, robust gross margin of 61.7%, and solid revenue and earnings growth of 12.1% and 17.8% respectively in the most recent quarter. Despite the…
SBUX β€” Starbucks Corporation
Starbucks Corporation operates a global coffeehouse chain with a strong brand and a leading digital/mobile platform, serving approximately 90 million customers weekly through over 28,000 stores in 77 countries. The company benefits from a durable competitive moat based on its extensive store footprint, brand recognition, and digital engagement rather than proprietary products. Despite solid reven…
Accumulation Zones
Metric KO SBUX
Zone Low $57.22 $70.88
Zone High $64.85 $80.33
In Buy Zone? No No
← KO Research    SBUX Research β†’    All Research